Published in Nitric Oxide on April 14, 2008
Recent advances in arginine metabolism: roles and regulation of the arginases. Br J Pharmacol (2009) 2.24
Arginine metabolism and nutrition in growth, health and disease. Amino Acids (2008) 2.13
Macrophages and inflammatory mediators in chemical toxicity: a battle of forces. Chem Res Toxicol (2009) 1.70
Reperfusion injury and reactive oxygen species: The evolution of a concept. Redox Biol (2015) 1.19
Citrulline a more suitable substrate than arginine to restore NO production and the microcirculation during endotoxemia. PLoS One (2012) 1.06
Arginase in retinopathy. Prog Retin Eye Res (2013) 0.94
Arginase inhibition in airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin. Toxicol Appl Pharmacol (2009) 0.93
Arginine depletion as a mechanism for the immune privilege of corneal allografts. Eur J Immunol (2011) 0.93
Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism. Kidney Int (2013) 0.87
Arginase 2 deficiency reduces hyperoxia-mediated retinal neurodegeneration through the regulation of polyamine metabolism. Cell Death Dis (2014) 0.86
Competitive metabolism of L-arginine: arginase as a therapeutic target in asthma. J Biomed Res (2011) 0.84
Arginase induction and activation during ischemia and reperfusion and functional consequences for the heart. Front Physiol (2015) 0.83
Topiramate ameliorates abdominal aorta cross-clamping induced liver injury in rats. Saudi J Gastroenterol (2014) 0.82
Arginase as a Critical Prooxidant Mediator in the Binomial Endothelial Dysfunction-Atherosclerosis. Oxid Med Cell Longev (2015) 0.77
Citrulline Supplementation Improves Organ Perfusion and Arginine Availability under Conditions with Enhanced Arginase Activity. Nutrients (2015) 0.77
Angiotensin II limits NO production by upregulating arginase through a p38 MAPK-ATF-2 pathway. Eur J Pharmacol (2014) 0.76
Hepatocyte-secreted extracellular vesicles modify blood metabolome and endothelial function by an arginase-dependent mechanism. Sci Rep (2017) 0.75
Effect of Pneumoperitoneum on Oxidative Stress and Inflammation via the Arginase Pathway in Rats. Yonsei Med J (2016) 0.75
Effect of infliximab on acute hepatic ischemia/reperfusion injury in rats. Int J Clin Exp Med (2015) 0.75
Quercetin and tin protoporphyrin attenuate hepatic ischemia reperfusion injury: role of HO-1. Naunyn Schmiedebergs Arch Pharmacol (2017) 0.75
Arginase-2 Mediates Renal Ischemia/Reperfusion Injury. Am J Physiol Renal Physiol (2017) 0.75
Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine (1999) 9.70
Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol (2005) 9.27
Arginine metabolism: nitric oxide and beyond. Biochem J (1998) 6.44
Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res (2004) 4.74
The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol (1995) 4.33
Determination of arginase activity in macrophages: a micromethod. J Immunol Methods (1994) 3.16
Hepatic ischemia/reperfusion injury--a fresh look. Exp Mol Pathol (2003) 2.81
Protective strategies against ischemic injury of the liver. Gastroenterology (2003) 2.37
Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. Am J Physiol (1998) 1.96
Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. Biochem Biophys Res Commun (1995) 1.89
Intestinal mucosal amino acid catabolism. J Nutr (1998) 1.65
Inhaled carbon monoxide suppresses the development of postoperative ileus in the murine small intestine. Gastroenterology (2003) 1.59
Effects of the new arginase inhibitor N(omega)-hydroxy-nor-L-arginine on NO synthase activity in murine macrophages. Nitric Oxide (1999) 1.38
The roles of iNOS in liver ischemia-reperfusion injury. Shock (2001) 1.28
The metabolic basis of arginine nutrition and pharmacotherapy. Biomed Pharmacother (2002) 1.13
N omega-hydroxyl-L-arginine, an intermediate in the L-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase. Biochem Biophys Res Commun (1994) 1.11
Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene. Shock (2000) 1.10
Blockade of the L-arginine/NO synthase pathway worsens hepatic apoptosis and liver transplant preservation injury. Hepatology (2002) 1.06
Substrate specificity of NO synthases: detailed comparison of L-arginine, homo-L-arginine, their N omega-hydroxy derivatives, and N omega-hydroxynor-L-arginine. Biochemistry (1998) 1.06
Carbon monoxide inhalation ameliorates cold ischemia/reperfusion injury after rat liver transplantation. Surgery (2005) 1.06
Liver I/R injury is improved by the arginase inhibitor, N(omega)-hydroxy-nor-L-arginine (nor-NOHA). Am J Physiol Gastrointest Liver Physiol (2006) 1.03
Trauma increases extrahepatic arginase activity. Surgery (2000) 1.02
Mechanism of hepatocyte death after ischemia: apoptosis versus necrosis. Hepatology (2001) 0.96
Remodeling of hepatic microvascular responsiveness after ischemia/reperfusion. Shock (1997) 0.87
Elevated plasma arginase-1 does not affect plasma arginine in patients undergoing liver resection. Clin Sci (Lond) (2008) 0.86
Enhanced intestinal synthesis of polyamines from proline in cortisol-treated piglets. Am J Physiol Endocrinol Metab (2000) 0.86
Role of thromboxane in producing hepatic injury during hepatic stress. Arch Surg (2005) 0.86
The protective effects of L-arginine after liver ischaemia/reperfusion injury in a pig model. J Pathol (1997) 0.86
Novel substrates for nitric oxide synthases. Bioorg Med Chem (2002) 0.85
A simple quantitative micromethod of arginase assay in blood spots dried on filter paper. Clin Chim Acta (1986) 0.84
Arginase release following liver reperfusion. Evidence of hemodynamic action of arginase infusions. Transplantation (1995) 0.83
Endothelial cell determinants of susceptibility to neutrophil-mediated killing. Shock (1999) 0.80
Improvement of cardiac output and liver blood flow and reduction of pulmonary vascular resistance by intravenous infusion of L-arginine during the early reperfusion period in pig liver transplantation. Transplantation (1997) 0.80
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med (2005) 6.86
World review of laparoscopic liver resection-2,804 patients. Ann Surg (2009) 5.96
The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg (2009) 5.33
HMGB1: endogenous danger signaling. Mol Med (2008) 4.02
HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med (2007) 3.72
Free radicals, antioxidants, and nutrition. Nutrition (2002) 3.66
Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol (2005) 2.78
Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. J Exp Med (2006) 2.77
Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. Shock (2006) 2.61
Robotic versus laparoscopic hepatectomy: a matched comparison. Ann Surg (2014) 2.58
Depression, immunity, and survival in patients with hepatobiliary carcinoma. J Clin Oncol (2007) 2.49
Amino acids and immune function. Br J Nutr (2007) 2.48
Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg (2015) 2.36
Oral hydrogen water prevents chronic allograft nephropathy in rats. Kidney Int (2009) 2.35
Ageing diminishes endothelium-dependent vasodilatation and tetrahydrobiopterin content in rat skeletal muscle arterioles. J Physiol (2007) 2.14
Laparoscopic major hepatectomy: an evolution in standard of care. Ann Surg (2009) 2.01
Production of free glutamate in milk requires the leucine transporter LAT1. Am J Physiol Cell Physiol (2013) 1.97
Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice. Hepatology (2011) 1.94
Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res (2007) 1.89
Comparative benefits of laparoscopic vs open hepatic resection: a critical appraisal. Arch Surg (2010) 1.85
Linking oxidative stress to inflammation: Toll-like receptors. Free Radic Biol Med (2010) 1.85
Treatment of hepatic epithelioid hemangioendothelioma: a single-institution experience with 25 cases. Arch Surg (2009) 1.82
Functions of autophagy in normal and diseased liver. Autophagy (2013) 1.81
High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity. J Biol Chem (2010) 1.79
Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. J Nutr Biochem (2006) 1.77
Minimally invasive liver resection for metastatic colorectal cancer: a multi-institutional, international report of safety, feasibility, and early outcomes. Ann Surg (2009) 1.74
Recent advances in hydrogen research as a therapeutic medical gas. Free Radic Res (2010) 1.65
Molecular biology of liver ischemia/reperfusion injury: established mechanisms and recent advancements. Surg Clin North Am (2010) 1.65
Effects of ageing and exercise training on eNOS uncoupling in skeletal muscle resistance arterioles. J Physiol (2009) 1.60
Watermelon consumption increases plasma arginine concentrations in adults. Nutrition (2007) 1.57
Biliverdin administration protects against endotoxin-induced acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol (2005) 1.49
Dietary arginine supplementation increases mTOR signaling activity in skeletal muscle of neonatal pigs. J Nutr (2008) 1.48
A stochastic model for cancer stem cell origin in metastatic colon cancer. Cancer Res (2008) 1.48
mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS. Blood (2010) 1.45
Dietary L-arginine supplementation reduces fat mass in Zucker diabetic fatty rats. J Nutr (2005) 1.44
Hydrogen-supplemented drinking water protects cardiac allografts from inflammation-associated deterioration. Transpl Int (2012) 1.44
Delayed operating room availability significantly impacts the total hospital costs of an urgent surgical procedure. Surgery (2011) 1.43
Adenosine injection prior to cardioplegia enhances preservation of senescent hearts in rat heterotopic heart transplantation. Eur J Cardiothorac Surg (2012) 1.42
Profiling molecular changes induced by hydrogen treatment of lung allografts prior to procurement. Biochem Biophys Res Commun (2012) 1.42
High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases. Hepatology (2012) 1.42
Cutting edge: high-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury. J Immunol (2006) 1.42
Biliverdin protects the functional integrity of a transplanted syngeneic small bowel. Gastroenterology (2004) 1.39
Laparoscopic liver resection. World J Surg (2011) 1.38
Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway. J Biol Chem (2002) 1.37
Glycine metabolism in animals and humans: implications for nutrition and health. Amino Acids (2013) 1.36
Extrahepatic portal vein aneurysm--report of six patients and review of the literature. J Gastrointest Surg (2007) 1.36
miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions. Gastroenterology (2012) 1.36
Activities of arginase I and II are limiting for endothelial cell proliferation. Am J Physiol Regul Integr Comp Physiol (2002) 1.35
Benzyl alcohol attenuates acetaminophen-induced acute liver injury in a Toll-like receptor-4-dependent pattern in mice. Hepatology (2014) 1.35
Regulation of human nitric oxide synthase 2 expression by Wnt beta-catenin signaling. Cancer Res (2006) 1.33
Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide. Am J Physiol Renal Physiol (2004) 1.33
Gene expression is altered in piglet small intestine by weaning and dietary glutamine supplementation. J Nutr (2008) 1.32
Dietary L-arginine supplementation increases muscle gain and reduces body fat mass in growing-finishing pigs. Amino Acids (2008) 1.32
Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene. Hepatology (2009) 1.31
New developments in fish amino acid nutrition: towards functional and environmentally oriented aquafeeds. Amino Acids (2008) 1.30
Beneficial effects of L-arginine on reducing obesity: potential mechanisms and important implications for human health. Amino Acids (2010) 1.30
Caveolin-1 expression by means of p38beta mitogen-activated protein kinase mediates the antiproliferative effect of carbon monoxide. Proc Natl Acad Sci U S A (2005) 1.29
Comparing the clinical and economic impact of laparoscopic versus open liver resection. Ann Surg Oncol (2009) 1.29
A mouse model of accelerated liver aging caused by a defect in DNA repair. Hepatology (2012) 1.29
Comparative aspects of implantation. Reproduction (2009) 1.28
Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury. J Leukoc Biol (2006) 1.27
Laparoscopic resection of benign hepatic cysts: a new standard. J Am Coll Surg (2008) 1.26
Identification of a negative response element in the human inducible nitric-oxide synthase (hiNOS) promoter: The role of NF-kappa B-repressing factor (NRF) in basal repression of the hiNOS gene. Proc Natl Acad Sci U S A (2002) 1.25
Novel pathways for implantation and establishment and maintenance of pregnancy in mammals. Mol Hum Reprod (2009) 1.24
IL-1beta-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells. J Immunol (2008) 1.22
Glutamine, arginine, and leucine signaling in the intestine. Amino Acids (2009) 1.22
Cellular-specific role of toll-like receptor 4 in hepatic ischemia-reperfusion injury in mice. Hepatology (2013) 1.21
The transcription factor interferon regulatory factor-1 mediates liver damage during ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol (2006) 1.21
Toll-like receptor 4 mediates the early inflammatory response after cold ischemia/reperfusion. Transplantation (2007) 1.21
Noninvasive radiofrequency ablation of cancer targeted by gold nanoparticles. Surgery (2008) 1.21
Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease. Hepatology (2012) 1.21
Regulation of tetrahydrobiopterin synthesis and bioavailability in endothelial cells. Cell Biochem Biophys (2004) 1.21
Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience. J Gastrointest Surg (2007) 1.19
High fat feeding and dietary L-arginine supplementation differentially regulate gene expression in rat white adipose tissue. Amino Acids (2009) 1.19
Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway. Cancer Res (2007) 1.19
Dietary L-arginine supplementation reduces white fat gain and enhances skeletal muscle and brown fat masses in diet-induced obese rats. J Nutr (2008) 1.19
Ethyl pyruvate ameliorates liver ischemia-reperfusion injury by decreasing hepatic necrosis and apoptosis. Transplantation (2005) 1.19
Role of NF-kappaB on liver cold ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol (2002) 1.19